Champlain Investment Partners, LLC Dexcom Inc Transaction History
Champlain Investment Partners, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Champlain Investment Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 2,213,283 shares of DXCM stock, worth $178 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
2,213,283
Previous 2,050,073
7.96%
Holding current value
$178 Million
Previous $232 Million
36.18%
% of portfolio
0.94%
Previous 1.47%
Shares
11 transactions
Others Institutions Holding DXCM
# of Institutions
1,014Shares Held
351MCall Options Held
5.51MPut Options Held
5.6M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.81 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.77 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.44 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.34 Billion0.05% of portfolio
-
Baillie Gifford & CO15MShares$1.21 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $31B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...